Last edition
News about "EBITDA margin"
Akums Drugs and Pharmaceuticals Reports 35.4 Percent EBITDA Growth in Q1 FY27
Akums Drugs and Pharmaceuticals starts FY27 on a strong note, reporting robust revenue, EBITDA and PAT growth as its CDMO business continues to drive performance.
EBITDA Margin | 11/08/2026 | By News Bureau
GSK India Reports 24 Percent PAT Growth in Q1 FY27
GSK India reported 15 percent revenue growth to INR 924 crore and a 24 percent rise in Q1 FY27 PAT to INR 253 crore, with EBITDA margin of 32 percent.
EBITDA Margin | 04/08/2026 | By News Bureau | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy